Kristopher Barnthouse

Title: Innovations by Kristopher Barnthouse

Introduction

Kristopher Barnthouse is an accomplished inventor based in Pottstown, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-TNF antibody compositions. With a total of 3 patents to his name, Barnthouse continues to push the boundaries of innovation in his field.

Latest Patents

Barnthouse's latest patents include groundbreaking methods for producing anti-TNF antibody compositions. One of his notable inventions focuses on manufacturing methods for producing recombinant anti-TNF antibodies, specifically those with a heavy chain comprising amino acid sequence SEQ ID NO:36 and a light chain comprising amino acid sequence SEQ ID NO:37. Another significant patent details methods for producing a recombinant anti-TNF antibody with a heavy chain comprising SEQ ID NO:38 and a light chain comprising SEQ ID NO:37, along with the compositions that include these antibodies.

Career Highlights

Kristopher Barnthouse is currently employed at Janssen Biotech, Inc., where he applies his expertise in biotechnology to develop innovative solutions. His work has been instrumental in advancing therapeutic options for patients suffering from various conditions related to tumor necrosis factor.

Collaborations

Barnthouse has collaborated with notable colleagues in his field, including Subinay Ganguly and Maarten Groeneveld. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of cutting-edge technologies.

Conclusion

Kristopher Barnthouse exemplifies the spirit of innovation in biotechnology through his patents and contributions to the field. His work at Janssen Biotech, Inc. and collaborations with esteemed colleagues highlight his commitment to advancing medical science.